<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03553511</url>
  </required_header>
  <id_info>
    <org_study_id>LULS-1</org_study_id>
    <nct_id>NCT03553511</nct_id>
  </id_info>
  <brief_title>Laparoscopic Hysterectomy With Vaginal Vault Suspension to the Uterosacral Ligaments for Stage II-III Pelvic Organ Prolapse.</brief_title>
  <acronym>LULS-1</acronym>
  <official_title>Short and Long-term Outcomes After Total Laparoscopic Hysterectomy With Vaginal Vault Suspension to the Uterosacral Ligaments Versus Vaginal Hysterectomy With McCall Culdoplasty for the Treatment of Stage II-III Pelvic Organ Prolapse.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi dell'Insubria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi dell'Insubria</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The International Continence Society defines post-hysterectomy vault prolapse (PHVP) as
      descent of the vaginal cuff scar below a point that is 2 cm less than the total vaginal
      length above the plane of the hymen. The incidence of PHVP has been reported to affect up to
      43% of hysterectomies. The risk of prolapse following hysterectomy is 5.5 times more common
      in women whose initial hysterectomy was for pelvic organ prolapse as opposed to other
      reasons.

      Techniques available to manage PHVP aim to ultimately suspend the vaginal vault. Approaches
      include vaginal, e.g. uterosacral ligament suspension, sacrospinous ligament fixation, open
      procedures and more recently laparoscopic, e.g. sacrocolpopexy and uterosacral plication.

      Data published so far do not allow to draw a firm conclusion about the best treatment to
      prevent PHVP for women undergoing hysterectomy for stage II-III pelvic organ prolapse.
      Considering this scenario, in the current study the investigators aim to evaluate short and
      long-term outcomes after total laparoscopic hysterectomy with vaginal vault suspension to the
      uterosacral ligaments versus vaginal hysterectomy with McCall culdoplasty for the treatment
      of stage II-III pelvic organ prolapse.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2019</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective Randomized Clinical trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>Vaginal vault prolapse</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary impact questionnaire score (total score minimum: 0, maximum: 100)</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>A specific questionnaire developed to investigate the impact of urinary symptoms and signs on the quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Organ Prolapse Impact Questionnaire (total score minimum: 0, maximum: 100)</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>A specific questionnaire developed to investigate the impact of prolapse-related symptoms and signs on the quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colorectal-Anal Impact questionnaire (total score minimum: 0, maximum: 100)</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>A specific questionnaire developed to investigate the impact of prolapse-related colorectal and anal symptoms and signs on the quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolapse/urinary incontinence sexual questionnaire score (total score minimum: 0, maximum: 48)</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>A specific questionnaire developed to investigate the impact of prolapse/urinary incontinence on sexual functions.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Uterosacral ligaments suspension</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women affected by stage II-III pelvic organ prolapse undergoing total laparoscopic hysterectomy with vaginal vault suspension to the uterosacral ligaments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>McCall culdoplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women affected by stage II-III pelvic organ prolapse undergoing vaginal hysterectomy with McCall culdoplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vaginal vault suspension to the uterosacral ligaments</intervention_name>
    <description>Laparoscopic hysterectomy with vaginal vault suspension to the uterosacral ligaments</description>
    <arm_group_label>Uterosacral ligaments suspension</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>McCall culdoplasty</intervention_name>
    <description>Vaginal hysterectomy with McCall culdoplasty</description>
    <arm_group_label>McCall culdoplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stage II-III pelvic organ prolapse

          -  Bilateral preservation of the ovaries

          -  Sexually active women

        Exclusion Criteria:

          -  Smoking

          -  Body Mass Index &gt; 30

          -  Strenuous activity (frequent heavy lifting)

          -  Other gynecological and non-gynecological (chronic endocrine, metabolic, autoimmune,
             neoplastic diseases) comorbidities

          -  Pharmacological and/or nonpharmacological treatment (including pelvic floor exercises)
             in the six months preceding the surgery or during the study period
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Simone Laganà, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jvan Casarin, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonella Cromi, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabio Ghezzi, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antonio Simone Laganà, M.D.</last_name>
    <phone>3296279579</phone>
    <phone_ext>+39</phone_ext>
    <email>antoniosimone.lagana@asst-settelaghi.it</email>
  </overall_contact>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 30, 2018</study_first_submitted>
  <study_first_submitted_qc>May 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2018</study_first_posted>
  <last_update_submitted>June 16, 2018</last_update_submitted>
  <last_update_submitted_qc>June 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi dell'Insubria</investigator_affiliation>
    <investigator_full_name>Antonio Simone Laganà</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Laparoscopy</keyword>
  <keyword>Hysterectomy</keyword>
  <keyword>Uterosacral ligaments suspension</keyword>
  <keyword>McCall culdoplasty</keyword>
  <keyword>Post-hysterectomy vault prolapse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

